A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.
Wiedenmann B, Malfertheiner P, Friess H, Ritch P, Arseneau J, Mantovani G, Caprioni F, Van Cutsem E, Richel D, DeWitte M, Qi M, Robinson D Jr, Zhong B, De Boer C, Lu JD, Prabhakar U, Corringham R, Von Hoff D.
Wiedenmann B, et al.
J Support Oncol. 2008 Jan;6(1):18-25.
J Support Oncol. 2008.
PMID: 18257397
Clinical Trial.